Understanding Sickle cell disease: Causes, symptoms, and treatment options.
Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayabazu CP, Aina TO, Aborisade O, Adenikinju JS.
Medicine (Baltimore). 2023 Sep 22;102(38):e35237. doi: 10.1097/MD.0000000000035237.
Advances in the diagnosis and treatment of sickle cell disease.
Brandow AM, Liem RI.
J Hematol Oncol. 2022 Mar 3;15(1):20. doi: 10.1186/s13045-022-01237-z.
Sickle-cell disease.
Rees DC, Williams TN, Gladwin MT.
Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.
Sickle cell disease: A primary care update.
Onimoe G, Rotz S.
Cleve Clin J Med. 2020 Jan;87(1):19-27. doi: 10.3949/ccjm.87a.18051. Epub 2020 Jan 2.
Sickle-cell disease.
Gravitz L, Pincock S.
Nature. 2014 Nov 13;515(7526):S1. doi: 10.1038/515S1a.
Sickle cell disease: a year in review.
The Lancet Haematology.
Lancet Haematol. 2022 Jun;9(6):e385. doi: 10.1016/S2352-3026(22)00144-2.
Treatment Options for Sickle Cell Disease.
Meier ER.
Pediatr Clin North Am. 2018 Jun;65(3):427-443. doi: 10.1016/j.pcl.2018.01.005.
Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.
Steinberg MH.
ScientificWorldJournal. 2008 Dec 25;8:1295-324. doi: 10.1100/tsw.2008.157.
Determinants of severity in sickle cell disease.
Rees DC, Brousse VAM, Brewin JN.
Blood Rev. 2022 Nov;56:100983. doi: 10.1016/j.blre.2022.100983. Epub 2022 Jun 9.
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
Hoppe C, Neumayr L.
Hematol Oncol Clin North Am. 2019 Jun;33(3):355-371. doi: 10.1016/j.hoc.2019.01.014. Epub 2019 Mar 28.
